Bill

HB 1199

INSURANCE/HEALTH: Provides relative to health insurance coverage for genetic testing and the treatment of SCN2A-associated medical conditions (EN NO IMPACT See Note)

2026 Regular Session Introduced by Gary Carter and 6 co-sponsors

Louisiana requires health insurers to cover SCN2A genetic testing and treatment without cost-sharing for patients with rare early-onset epilepsy-causing mutations.

Effective date: 06/09/2026.

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Versions

House Committee Amendment, #4334, INS, Draft www.legis.la.gov

Senate Committee Amendment, #4488, INS, Adopted www.legis.la.gov

Senate Committee Amendment, #4486, INS, Draft www.legis.la.gov

House Committee Amendment, #4379, INS, Proposed www.legis.la.gov

HB1199 Enrolled www.legis.la.gov

HB1199 Original www.legis.la.gov

HB1199 Act 884 www.legis.la.gov

HB1199 Engrossed www.legis.la.gov

House Committee Amendment, #4379, INS, Adopted www.legis.la.gov

Bill text & amendments

Summary of Senate Amendments to HB1199 Digest of HB1199 Engrossed Senate Green Sheet Digest for HB1199 Digest of HB1199 Original

New to WeVote?

Join free to follow the races on your ballot, compare candidates, and weigh in.

Create account Sign in

Trending proposals

SONDRA COSGROVE Protect the right to run ballot questions in Nevada. 1% 3 of 500

SONDRA COSGROVE Treat all voters equally in taxpayer funded elections 0% 2 of 500

View all proposals

Support our mission

WeVote is free and nonpartisan — powered by small donations from voters like you.

Make a donation

WeVote is nonpartisan and does not endorse candidates or parties.